James B. Caress, M.D., Associate Professor Neurology-Neuromuscular

James B. Caress, M.D.

Associate Professor, Neurology

Clinical Specialties

Myasthenia Gravis, ALS, Muscle Diseases, Muscle Cramps

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4101
Department: 336-716-7668

Education & Training

B.A., Colgate University , 1986
M.D., George Washington University School of Medicine , 1990
Internship, Internal Medicine, George Washington U Hosp, 1991
Residency, Neurology, Duke University Medical Center, 1994
Fellowship, Brigham & Women's Hosp, 1996

Board Certifications

American Board of Psychiatry & Neurology, Neuromuscular Medicine
American Board of Psychiatry & Neurology, Neurology
American Board of Psychiatry & Neurology, Neurology, Clinical Neurophysiology
American Board of Psychiatry & Neurology, Neurology, Neuromuscular Medicine

Memberships

Am Academy Of Neurology

NPI Number

1184600264

James B. Caress, M.D.

Associate Professor, Neurology

Research Interests

drugs/therapeutic agents pharm, neurosciences/behavior

Contact Information

Academic: 336-716-2309 | Department: 336-716-7668

Recent Publications

Rutkove S, Caress J, Cartwright M, Burns T, Warder J, David W, Goyal N, Maragakis N, Clawson L, Benatar M, Usher S, Sharma K, Guatam S, Narayanaswarmi P, Raynot E, Watson ML, Shefner J. Electrical impedance myography as a biomarker to assess ALS progression [abstract]. Neurology. 2012;78(Suppl 1):S25.006.

Gifondorwa DJ, Jimenz-Moreno R, Hayes CD, Rouhani H, Robinson MB, Strupe JL, Caress J, Milligan C. Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurol Res Int. 2012;2012():170426.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson ML, Shefner JM. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler. 2012;13(5):439-445.

Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB. Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology. 2011;77(3):235-241.

Cartwright MS, Walker FO, Griffin LP, Caress JB. Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(3):346-351.

Caress JB. Bleeding and electromyography: the needle and the damage (not) done [editorial]. Muscle Nerve. 2011;44(3):313-315.

Caress JB, Kennedy BL, Eickman KD. Safety of intravenous immunoglobulin treatment. Expert Opin Drug Saf. 2010;9(6):971-979.

Hernandez S, Texido L, Caldero J, Ciutat D, Piedrafita L, Casanovas A, Caress J, Prevette D, Oppenheim RW, Milligan C, et al. Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease. J Neuroimmunol. 2010;229(1-2):157-168.

Quaid KA, Swenson MM, Sims SL, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Caress J, Walker F, Hunt V, et al. What were you thinking?: individuals at risk for Huntington Disease talk about having children. J Genet Couns. 2010;19(6):606-617.

Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS. Case-control study of thromboembolic events associated with IV immunoglobulin. J Neurol. 2009;256(3):339-342.

Cartwright MS, Brown ME, Eulitt P, Walker FO, Lawson VH, Caress JB. Diagnostic nerve ultrasound in Charcot-Marie-Tooth disease type 1B. Muscle Nerve. 2009;40(1):98-102.

Yoshikawa M, Vinsant S, Mansfield CM, Gifondorwa DJ, Pace L, Messi LM [sic] [Messi ML], Caress J, Cartwright M, Delbono O, Oppenheim RW, Milligan CE, et al. Identification of changes in muscle, neuromuscular junctions and spinal cord at early pre-symptomatic stages in the mutant SOD1 mouse model of ALS may provide novel insight for diagnosis and treatment development [abstract]. Soc Neurosci Abstr. 2009;2009(Neuroscience Meeting Planner):.

Cartwright MS, Passmore LV, Yoon J-S, Brown ME, Caress JB, Walker FO. Cross-sectional area reference values for nerve ultrasonography. Muscle Nerve. 2008;37(5):566-571.

Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D, Al-Lozi M, Caress JB, David W, Russell J, Graves M, et al. Revised statistical motor unit number estimation in the Celecoxib/ALS trial. Muscle Nerve. 2007;35(2):228-234.

Caress JB, Esper GJ, Rutkove SB. Neurophysiology of nerve conduction studies In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 207-216.

Caress JB. Technical, physiological and anatomic considerations in nerve conduction studies In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 217-227.

Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2007;27(48):13173-80.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Donofrio P, Caress J, Ashburn C, Walker T, Dryman B, et al. Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60(1):22-31.

Shoulson I, Kieburtz K, Oakes D, Kayson E, Zhao H, Shinaman A, Romer M, Caress J, Walker F, Hunt V, et al. At risk for Huntington disease: the PHAROS (Prospective Huntington At Risk Observational Study) Cohort enrolled. Arch Neurol. 2006;63(7):991-996.